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Abstract 13 
Ethnobotanical relevance: Piper guineense occurs commonly in West Africa where it is used for 14 
fungal infections instead of the costly and not always accessible conventional antifungals. Fungal, 15 
yeast-based diseases are common in West-Africa especially among those living with HIV/ AIDS, 16 
and thus this study was performed in Imo state, South-Eastern Nigeria, where P. guineense is 17 
predominantly used for the treatment of fungal diseases, such as skin rashes, oral thrush and 18 
vaginosis. 19 
Aim of study: The scarce number of previous studies on the documentation of the traditional uses of 20 
P. guineense extracts for the treatment of fungal infections in Nigeria prompted this survey. The 21 
investigation focused on how traditional healers recognize and diagnose fungal infections, how P. 22 
guineense is collected, on the various parts used for the treatments, methods of preparations, 23 
administrations and treatments. In addition, an in vitro antifungal screening of P. guineense fruit 24 
and leaf extracts of various polarities, and piperine and piperlongumine, representing the main 25 
constituents in these extracts, were performed. 26 
Methods:  A house to house ethnobotanical survey was conducted using questionnaires. Twenty 27 
traditional medical practitioners (TMP) and herb sellers from ten villages were interviewed. Four 28 
human pathogenic strains of yeast and Cryptococcus neoformans, a yeast-like basidiomycete 29 
causing meningitis in immunocompromised individuals, were used for the antifungal screening. 30 
Results: The traditional medical practitioners (TMP) and herb sellers explained that the leaves and 31 
fruits are the most commonly used plant parts for the treatments. The oral intake of the extracts in 32 
locally produced bamboo alcohol (Kai-kai) is the most common method of administration. In 33 
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accordance with these recorded traditional uses, we found that extracts of P. guineense were growth 34 
inhibitory against the fungal strains with MIC values ranging from 39 to 2500 µg/mL. The lowest 35 
MIC value of 39 µg/mL was recorded for a methanol fruit extract against Candida albicans, C. 36 
glabrata and C. tropicalis. In addition, ethanol and hexane fruit extracts were effective against the 37 
growth of C. albicans and C. glabrata, respectively, with a MIC of 78 µg/mL. Piperlongumine and 38 
piperine were active against C. albicans with MIC values of 39 and 78 µg/mL respectively.  39 
Conclusion: P. guineense fruit and leaf extracts, as well as their piperamide alkaloid constituents 40 
piperine and piperlongumine, have interesting antifungal properties and could have potential as new 41 
antifungal scaffolds. Our results warrant further in-depth investigations to isolate and characterize 42 
piperamide alkaloids and other compounds responsible for the antifungal activity in the extracts.  43 
 44 





Africa is richly endowed with medicinal plants that are utilized in the treatment of fungal diseases 50 
in traditional medicine and thus could be sources for standardized antifungal extracts and antifungal 51 
compounds. Examples of such plant species are Jatropha curcas L. (Euphorbiaceae), Monodora 52 
myristica Dunal. (Annonaceae), Xylopia aethiopica A. Rich. (Annonaceae) and Piper guineense 53 
Schumach &Thonn (Piperaceae) (Ngane et al., 2003; Abdelgadir and Van Staden, 2013; Dzoyem 54 
and Kuete, 2013). The mortality rate associated with fungal diseases is high in Africa especially 55 
among those living with HIV/ AIDS (Park et al., 2009). Due to the high cost of conventional 56 
medicine and accessibility of numerous medicinal plants in Sub-Saharan Africa, 70- 80% of the 57 
population use traditional medicine and plant-based preparations for the treatment of infectious 58 
diseases (Agyare et al., 2018). In most rural villages in Africa, the conventional health-care 59 
professionals are limited and there are no adequate health-care facilities, and thus, majority of the 60 
people patronize the traditional medical practitioners who use the readily available herbal 61 
formulations for the treatment of fungal infections (Osuchukwu et al., 2017).  62 
African guinea pepper (Piper guineense Schumach &Thonn) is a medicinal plant and a spice that is 63 
highly valued in Africa because of its numerous ethno-medicinal uses (Besong et al., 2016; Ajibesin 64 
et al., 2011, Mgbeahuruike et al., 2017, 2018). The extracts of P. guineense are used to treat topical 65 
fungal diseases in West-African traditional medicine (Ngane et al., 2003). It is a vine that can grow 66 
up to 20 m in length with edible leaves and peppercorn fruits that have a strong pungent aroma 67 
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(Freiesleben et al., 2015). P. guineense is used for the preparation of herbal formulations for the 68 
treatment of numerous ailments and infectious diseases (Obodozie et al., 2010; Asase et al., 2012). 69 
Research has shown that fractions, natural compounds and extracts from P. guineense can be 70 
explored as antifungal preparations and agents for the prevention of skin infections (Ngane et al., 71 
2003). In another study, it was established that P. guineense extracts could be used as botanical 72 
fungicides by local farmers because of the high cost and toxicity associated with synthetic 73 
fungicides (Asawalam, 2006). According to previous research, herbal formulations from medicinal 74 
plants are often more effective and safer than those from isolated active compounds (Fabricant and 75 
Farnsworth, 2001), and thus standardized extracts could be used in the combat against fungal 76 
infections to minimize the risk of the development of resistance.  77 
 78 
Table 1. Summary of ethno-medicinal uses, pharmacology/antifungal screening of Piper guineense. 79 
P. guineense 
plant part 
Ethno-medicinal uses with 
reference source 
Pharmacology/ Antifungal activity 
with reference source 
In vivo/ In vitro 
Seeds/ Fruits 
 
Seeds are used to prepare 
decoctions for the treatment of 
fungal infections (Ngane et al., 
2003). Seeds and fruits in 
combination with other medicinal 
plants such as Xylopia aethiopica 
(Annonaceae) is boiled and 
administered to nursing mothers to 
aid the contraction of the uterus 
(Okigbo and Igwe, 2007).  
 
Agar diffusion method with 90% 
ethanolic extract and fractions 
obtained by column chromatography. 
Amphotericin B, Griseofulvin and 
Clotrimazole at 10 μg/mL each were 
used as positive controls. MIC 
against Candida albicans, 
Cryptococcus neoformans, 
Scopulariopsis brevicaulis, 
Aspergillus flavus, and Microsporum 
gypseum were within the range of 50 
-100 μg/mL for the extracts (Ngane et 
al., 2003). 
In vitro and in vivo (Ngane et 
al., 2003). 
 Seeds are used to prepare 
decoctions for the treatment of 
asthma and psychotic disorder 
(Gbekley et al., 2017; Oyemitan et 
al., 2015). The fruits are used for 
respiratory infections, female 
infertility, and aphrodisiac 
(Dzoyem et al., 2014). Fruits are 
used to prepare decoctions with 
other herbs to treat epilepsy (Abila 
et al. 1993). 
The fruits were extracted with a 
mixture of methanol-
dichloromethane (3:1 V/V) for 48 h 
at room temperature. Broth micro-
dilution method was used, Nystatin 
was used as positive control, MIC 
was between  1.56 to 6.25 mg/mL 
against Candida albicans, Candida 
parapsilosis, Candida tropicalis, 
Candida krusei, Candida glabrata  
and Cryptococcus neoformans 
 (Dzoyem et al., 2014) 
In vitro (Dzoyem et al., 2014). 
 Used for cough, bronchitis, 
rheumatism and syphilis (Konning 
et al., 2004; Sandberge et al., 2005). 
The fruits are used to prepare Yaji 
soup which is eaten as an 
aphrodisiac in West African 
countries (Ibrahim et al., 2010). 
Agar diffusion method, Soxhlet 96% 
methanol extracts. Clotrimazole was 
used as a positive control, inhibition 
zones were between 7.4 to 9.8 mm 
against Candida albicans and 
Aspergillus niger (Konning et al., 
2004). 
In vitro (Konning et al., 
2004). 
 
 It is mixed with other herbs to 
produce Niprisan used in herbal 
medicine in West Africa for the 
treatment of sickle cell anemia 
(Obodozie et al., 2010, Freiesleben 
et al., 2015).  
 
Petroleum ether extract obtained by 
Soxhlet extraction, aqueous extract 
and 95 % ethanolic extract. MIC was 
200 mg/mL against Aspergillus niger, 
No positive control was mentioned 
(Ebana et al., 2016). 
In vitro (Ebana et al., 2016). 
 
Leaves Leaves have anticonvulsive Petroleum ether extract obtained by In vitro (Ebana et al., 2016). 
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activities and are used to make 
decoctions for the treatment of 
convulsion (Abila et al., 1993). 
Leaves are boiled with Xylopia 
aethiopica and taken for the 
treatment of malaria (Asase et al., 
2012).  
Soxhlet extraction, aqueous extract 
and 95 % ethanolic extract. MIC was 
80 mg/mL against against Aspergillus 
niger, Significant antifungal activity 
was observed. No positive control 
was mentioned (Ebana et al., 2016). 
 
 Leaves are used to prepare soup for 
the treatment of sexually 
transmitted diseases (Ajibesin et al., 
2011).  
 
Hexane and ethanol extracts. The 
diameter of the inhibition zones were 
11.0-34.0 mm against Aspergillus 
niger and Aspergillus flavus (Dada et 
al., 2013). 
In vitro (Dada et al., 2013). 
 
 Used for the treatment of dysentery 
and bronchitis (Ogunniran et al., 
2009). 
Water extracts obtained by 
maceration. 5, 10 and 15 % 
concentration of the water extract 
was used. The extracts were effective 
against Fusarium oxysporum at 
higher concentrations of 10 and 15 % 
(Abiala et al., 2015). 
In vitro (Abiala et al., 2015). 
Root No references found No references found No references found 
 80 
This present study is the first report resulting from an ethnobotanical survey on the traditional uses 81 
of P. guineense extracts for the treatment of fungal infections, including candidiasis, in South-82 
Eastern Nigeria. Due to the frequent occurrence of fungal diseases in West Africa, this study was 83 
performed in Imo state, South-Eastern Nigeria, where P. guineense is predominantly used for the 84 
treatment of fungal diseases and for other various medicinal purposes. Imo state is one of the five 85 
states in South-Eastern Nigeria. The people in Imo state belong to the Igbo ethnic group and are 86 
predominantly Christians. This study area was selected because of the prevalence of fungal 87 
infections in the area, owing to the fact that it is a rain forest zone and the humid climate favours the 88 
occurrence of topical fungal infections. The area was also selected due to the fact that no previous 89 
investigations on the ethnopharmacology of P. guineense have been performed in this region.  90 
Moreover, the area is inhabited by over 4.8 million people, who largely cultivate P. guineense and 91 
depend on this species and other medicinal plants for the treatment of infectious diseases and 92 
among them fungal infections. Also, the people have a diverse cultural and historical background, 93 
and are well grounded with the knowledge of traditional medicine. However, this valuable 94 
traditional medicinal knowledge is usually not documented. Thus, the aim of the study was to 95 
conduct an ethnobotanical survey in order to document the ways in which traditional healers and 96 
herb sellers utilize P. guineense extracts and preparations for the treatment of fungal diseases. The 97 
investigation was focused on how fungal infections are recognized and diagnosed, how and which 98 
parts of P. guineense are collected, methods of preparations, administrations and treatments. To 99 
validate the ethnobotanical information, an in vitro screening of P. guineese extracts of the fruit and 100 
leaf was performed against selected human pathogenic Candida spp. and Cryptococcus neoformans 101 





2. Materials and methods 105 
2.1 Study area and survey 106 
Imo state is situated in South-Eastern Nigeria and share boundary with the South-South geo-107 
political zone of Nigeria. It is a tropical rain forest zone located between 4°45 -7°15N and 6°50 - 108 
7°25E, covering a total land area of 5,530 km2 (Fig. 1). An ethnobotanical survey was conducted in 109 
Imo state, where P. guineense is frequently used as herbal remedy in the treatment of candidiasis 110 
and other fungal diseases. The field work was conducted in ten localities between November and 111 
December 2017. A total of 20 traditional healers and herb sellers were interviewed (two from each 112 
locality).  The purpose of the work was to validate the use of P. guineense in the treatment of fungal 113 
diseases. The 10 localities visited during the interviews were chosen by random sampling technique 114 
and are not clustered, but are all distributed within the three senatorial districts in Imo state as seen 115 




Fig 1.  Map of Nigeria showing the study area (Imo state) shaded in black and Map of Imo state 120 
showing the 10 localities shaded in colours. Source, Eunice Ego Mgbeahuruike, University of 121 






2.2 Data collection 126 
In the ethnobotanical survey, a house to house strategy was used with the permission of the village 127 
heads and traditional rulers. First, an ethical consideration of the project was done appropriately and 128 
approved by the University of Helsinki ethical committee, the survey plan was also approved by the 129 
head of the Division of Pharmaceutical Biosciences of the University of Helsinki, Finland.  The 130 
village heads were notified prior to the investigation and the traditional healers were also well 131 
informed. The investigating team obtained an ethical approval from each of the village heads. The 132 
individual traditional healers gave an informed consent for the use of the data and pictures obtained 133 
during the interview. The consent was an oral agreement which was obtained from each of the 134 
traditional healers before the interviews began and permission to publish any photographs resulting 135 
from the interviews was obtained too. Detailed and validated questionnaires (Appendix A) were 136 
administered to twenty traditional healers (2 from each locality). This was followed by series of 137 
questions and conversations, so as to obtain the information needed for the work. The 138 
questionnaires were written in English, but the local language (Igbo) was used during the interviews 139 
and conversations because most of the participants could not interact well in English even though 140 
they had formal education. The traditional healers provided samples of the leaves, and fruits of P. 141 
guineense which was identified by a member of the investigating team who is a botanist. The 142 
traditional healers cooperated with our investigating team and some cash gifts were given to them at 143 
the end of the survey.  144 
 145 
2.3 Plant material for antifungal screening 146 
The fruits and leaves of P. guineense (African guinea pepper) used in this study were collected from 147 
a rural village in Imo State, South Eastern Nigeria. The plant materials were authenticated at the 148 
Department of Crop Science of the Federal University of Technology, Owerri, Nigeria. Voucher 149 
specimens are deposited in the herbarium of the Department of Crop Science of the same university 150 
with the specimen number FUTO/SAAT/NS/005A for the fruit and FUTO/SAAT/NS/005B for the 151 
leaf. 152 
 153 
2.4 Extraction  154 
The air dried plant materials were milled with a grinder to obtain finely ground powdery samples. 155 
Sequential extraction was carried out using solvents of varying polarities, starting with the least 156 
polar solvent. First, 40 g of the plant material was extracted with 300 mL of hexane, followed by 157 
extraction with 300 mL of chloroform, then 300 mL of ethanol and the residue was finally extracted 158 
and washed with 300 mL of methanol. Fruits and leaf plant materials were used for the extractions.  159 
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The extraction with each of the solvents was conducted in duplicates and each extract, except from 160 
the water extracts, were filtered using filter paper (Whatman GE Healthcare, Chicago, IL, USA). 161 
The water extracts were centrifuged at 689 g for 5 minutes. For each extract, the filtrate was 162 
evaporated using a rotary evaporator (Rotavapor, Heidolph VV2000) combined with a water bath 163 
not exceeding +40C, thereafter the extracts were lyophilized for two days to dry completely. 164 
Macerations and hot water decoctions were also prepared from the plant samples since these 165 
preparations are used in traditional medicine. Macerations were prepared by weighing 10 g of the 166 
fruits and leaf plant materials into Erlenmeyer flasks. 100 mL of water was added and extraction 167 
was performed for 24 hours using a magnetic stirrer. The mixture was centrifuged at 689 g for 15 168 
min (Eppendorf AG centrifuge 5810R, Germany). For the decoctions, 10 g of the plant material was 169 
boiled with 100 mL of water and allowed to cool. The mixture was centrifuged for 15 min at 689 g 170 
(Eppendorf AG centrifuge 5810R, Germany). Both the macerations and decoctions were carefully 171 
filtered using filter paper (Schleicher & Schuell, ∅=150 mm, Germany), and freeze dried for two 172 
days in a lyophilizer. Prior to the agar diffusion test, the freeze dried extracts were reconstituted and 173 
re-dissolved in their corresponding solvents or in MeOH to a final concentration of 50 mg/mL for 174 
the antifungal screening according to the method of Anyanwu and Nwosu, (2014) and Salih et al., 175 
(2017). 176 
 177 
2.5 Fungal strains 178 
The fungal strains used in this investigation were obtained from the Division of Pharmaceutical 179 
Biosciences, Faculty of Pharmacy, University of Helsinki, Finland. In all, the growth inhibitory 180 
activity of the extracts were investigated using five fungal strains (Candida albicans ATCC 10231, 181 
Candida glabrata ATCC 2001, Candida tropicalis ATCC 750, Candida parapsilosis ATCC 7330, 182 
and Cryptococcus neoformans ATCC 10226). 183 
 184 
2.6 Antibiotics and pure compounds  185 
Amphotericin-B (Sigma-Aldrich, St. Louis MO, USA) and itraconazole (Sigma-Aldrich, St. Louis 186 
MO, USA), were used as standard antibiotics for the investigation. Analytical grade piperine and 187 
piperlongumine standards (≥ 97.0% purity) purchased from TCI Europe N.V.  (Zwijndrecht, 188 
Belgium) were used as standard compounds. 189 
 190 
2.6.1 Agar disk diffusion method 191 
Four human pathogenic strains of yeast and Cryptococcus neoformans, a yeast-like basidiomycete, 192 
were used to investigate the growth inhibitory effects of P. guineense extracts. A total of twelve 193 
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extracts from the fruits and leaf extracts of this plant were tested against the fungi. An agar disk 194 
diffusion method was applied for the initial screening according to Salih et al., (2017). The freeze 195 
dried extracts were re-dissolved in those solvents used originally for their extraction according to 196 
the method of Anyanwu and Nwosu, (2014). Each of the extracts were prepared to a final 197 
concentration of 50 mg/mL (stock solution). Amphotericin-B and itraconazole were used as positive 198 
controls. The antibiotics were dissolved in methanol to a final concentration of 10 mg/mL used for 199 
the test. Sterile petri dishes (∅ =15 cm, VWR Finland) were used for the screening. For the 200 
screening, twenty-five mL of sterile base agar (Antibiotic agar No. 2, Difco, VWR Finland) was 201 
applied as a bottom layer into the sterile petri dishes using a sterile, serological pipet (Falcon, 202 
Becton Labware Europe) and allowed to solidify. Thereafter twenty-five mL of Saboraud agar 203 
(OXOID, Thermo Fisher Scientific) was applied as the top layer. The petri dishes were all allowed 204 
to solidify, and then stored in +4C. The screening started with inoculation of the fungal strains 205 
onto solid Saboraud agar slants which were incubated for 48 h at +37°C. The viable yeast cultures 206 
from the agar slants were used to prepare an inoculum for the test. Fungi from the agar slants were 207 
transferred into 2 mL of 0.9% (w/v) sodium chloride (NaCl) solution in a sterile glass tube using a 208 
sterile inoculation loop. 1 mL of the suspension was transferred into another sterile glass tube, and 209 
the absorbance was measured at 625 nm (UV–Visible Spectrophotometer, Pharmacia LKB-210 
Biochrom 4060). The other 1 mL of the suspension (sterile part) was diluted with the 0.9% NaCl 211 
solution so that the absorbance at 625 nm becomes 0.1 (this suspension contains approximately 1.5 212 
 108 CFU /mL). 200 µL of this diluted fungal suspension was spread evenly on each petri dish and 213 
left to dry for some seconds with the lid open. A sterile cork borer (11mm diameter) was used to 214 
make six holes equidistantly from each other on the agar surface of the petri dishes. 200 µL of the 215 
50 mg/mL plant extracts and 200 µL of the 10 mg/mL antibiotics were carefully pipetted into the 216 
holes respectively. Methanol, ethanol, hexane and chloroform, 200 µL of each, were used as solvent 217 
controls respectively. The solvents were found not to inhibit the growth of the fungi. The petri 218 
dishes were incubated at +4 °C for 1 h, and thereafter they were incubated for 48 h at +37 °C. The 219 
diameters of the zones of inhibition were measured with a caliper under a petri dish magnifier and 220 
expressed as the mean of the diameters of three replicates ± SEM.  221 
The Activity index (AI) of the various extracts were measured in relation to the standard antibiotics 222 
Amphotericin-B and itraconazole according to Fyhrquist et al., (2014). 223 
 224 
Thus, AI = Inhibition zone of the plant extract 225 




2.6.2 Microdilution turbidimetric broth method for MIC and MFC estimation  228 
From the result obtained from the agar disk diffusion assay, minimum inhibitory concentration 229 
(MIC) was estimated for some selected extracts based on their good antifungal activity. MIC is 230 
considered to be the lowest concentration of an extract or compound resulting in the inhibition of at 231 
least 90% of the growth of a fungal strain. MIC values were determined using a microdilution 232 
turbidimetric broth method based on the guidelines of Clinical and Laboratory Standards Institute 233 
(2012). Only extracts which expressed marked antifungal activity in the agar disk diffusion assay 234 
were tested for MIC. For the MIC evaluation, two-fold serial dilutions of the extracts from 9.75-235 
2500µg/mL were prepared in sterile Saboraud broth. Commercial pure compounds, piperine 236 
(1mg/mL concentration in methanol) and piperlongumine (1mg/mL concentration in methanol) 237 
were also two-fold serially diluted in Saboraud broth. Itraconazole and amphotericin-B were each 238 
two-fold serially diluted in Saboraud broth from 0.48-125 µg/mL respectively.  96 well microtiter 239 
plates were used for the tests (Nunc, Nunclone, Denmark). The fungal cultures were inoculated on 240 
Saboraud agar slants or in 5 mL Saboraud broth and grown for 48 hours at +37°C before the test. 241 
The absorbance of 1 mL of the 48 h fungal culture was measured for turbidity at λ = 625 nm using a 242 
UV–Visible Spectrophotometer type 1510 (Thermo Fisher Scientific Oy). The absorbance was 243 
adjusted to 0.1 at 625 nm (approximately 1.0 × 108 CFU/mL). 100 µL of this suspension A625= 0.1 244 
was further diluted 100-fold to get a working suspension or inoculum containing 1.0  106 245 
CFU/mL. 100 µL of this inoculum, and 100 µL of the plant extracts, pure compounds, antibiotics, 246 
and solvent controls, were pipetted into the 96 well microtiter plates. Therefore, each well contained 247 
5 × 105 CFU/mL. The solvent controls contained a maximum of 5 % (v/v) of each solvent to be 248 
tested for toxicity. At this concentration the solvents were found not to be toxic. The growth control 249 
(GC wells) contained only the fungal suspension, and the test wells (T wells) contained plant 250 
extracts or pure compounds + fungal suspension. Moreover, sample controls wells were prepared 251 
for each plant extract/compound to be tested, and these wells contained plant extract/pure 252 
compound and the broth only. The microwell plates were incubated for 48 hours in an incubator 253 
coupled to a shaker at +37C. The turbidity of the wells at λ = 620 nm was recorded using a Victor 254 
1420 spectrophotometer (Wallac, Finland). The tests were done in triplicate and the % growth was 255 
expressed as the mean of these triplicates  standard error of mean (SEM). The minimum fungicidal 256 
concentration (MFC) was evaluated by pipetting 100 µL from those wells of the microtiter plate, 257 
which contained the MIC concentration as well as 2 and 4 times higher concentrations than their 258 
MIC values on petri dishes ( = 9 cm) containing Saboraud agar, and incubating the dishes for 48 259 
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hours at +37°C.  The MFC was taken as the lowest concentration where no visible growth on the 260 
petri dish was observed after the incubation. 261 
 262 
3. Results and discussion 263 
3.1 Ethnobotanical survey and field study 264 
An ethnobotanical survey was carried out in Imo state in South-Eastern Nigeria, as shown in Fig. 1.  265 
During the interviews and conversations, the various methods of preparations and administrations 266 
of the decoctions and concoctions from the roots, leaves, and fruits of P. guineense for the treatment 267 
of fungal diseases, were widely explained by the traditional healers. 20 traditional healers (14 male 268 
and 6 female) were interviewed with the cooperation of their village heads. The participants were 269 
between the ages of 40 to 70 years. In the communities visited, it was observed that most of the 270 
traditional healers are of older age and have long been practicing traditional medicine. It was also 271 
observed that there were more male than female traditional healers and this is in line with previous 272 
findings that there are more male than female traditional healers in Africa (Cheikhyoussef, et al., 273 
2011; Ngarivhume et al., 2015). The socio-economic characteristics of the respondents are shown in 274 
Table 2.  275 
 276 
Table 2. Demographic characteristics of the respondents (n=20) 277 
Parameters Specifications Number of Respondents 
Gender Male 14 
 Female 6 
Occupation Herbalist 7 
 Traditional medical practitioners 5 
 Traditional healers/ herb sellers 8 
Age 20 - 35 0 
 36 - 55 9 
 56 - 75 11 
Year of practice (experience) 1 – 15 years 6 
 16 -30 years 9 
 31 years and above 5 
Learning/source of knowledge of 
traditional medicine 
Inherited and learnt from parents 12 
 Training from other herbalists 8 
Level of Education University education 3 
 High school 8 
 Primary education 6 
 No formal education 3 
Religion Christianity 16 
 Traditionalist 4 
 Islam 0 
 278 
Interestingly, most of the traditional healers have remarkable experience in traditional medicine and 279 
have inherited and learnt the practice from their parents. All the participants have practiced herbal 280 
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medicine for a long period of time, and 11 out of the 20 participants have practiced traditional 281 
medicine for over 25 years as their only source of income. Notably, some of the participants also 282 
had university education and thus some of the information on the preparation of P. guineense they 283 
also had in written form. One of the traditional healers has a big herbal clinic where he displayed 284 
various herbal preparations from P. guineense and he is referred to as “Doctor” in his community.  285 
It was observed during the course of this study that most of the traditional healers could read and 286 
write, that is to say that the trend in traditional medicine in Africa is gradually changing to become 287 
a modern profession. It was also observed that some of the traditional healers have books where 288 
they recorded the name of each patient and the treatments.  From the survey, a variety of herbal 289 
preparations from various parts of P. guineense were identified. The respondents explained the 290 
sources from which they obtain the plant materials for their traditional healing practice. Most of 291 
them, apart from traditional healing practice, are also farmers. They have farms within their yards 292 
where they planted P. guineense and other medicinal plants to be used for the treatment of various 293 
infectious diseases and for the purpose of making local profit. The participants explained that they 294 
sometimes sell P. guineense fruits and leaves in local markets as spices and medicine to the general 295 
population. This illustrates that the traditional healers do not have problems in getting the plant 296 
materials used for the herbal treatments since they are sold in the local markets. All the respondents 297 
gave similar explanations on the symptoms and methods of diagnosis of the fungal infections. The 298 
traditional healers explained that they could differentiate between bacterial, viral and fungal 299 
infections based on the symptoms they observe in their patients especially when it comes from 300 
fungal skin infection and oral thrush. They argued that it was easy for them to identify and 301 
differentiate between these infections owing to their long time practice of traditional medicine.  302 
They gave some common symptoms for the various fungal infections as shown in Table 3. The 303 
method of preparation ranges from hot infusion, decoction in combination with Xylopia aethiopica 304 
and then the plant material is soaked in mild alcohol as shown Table 3. 305 
 306 
The traditional healers understood the dangers of fungal infections and sometimes send their 307 
patients to the government hospitals if the symptoms persist as a result of their failed treatment or 308 
lack of proper understanding of the type of fungal infection. The participants explained widely the 309 
methods of administration of P. guineense extracts. The oral intake is the most common method of 310 
administration and these correlates with the findings of Maroyi, (2013) that herbal preparations are 311 
mostly administered orally by traditional healers. The traditional healers argued that the decoctions 312 
made from the fruits and leaves, prepared in mild alcohol is mostly effective when administered 313 
orally for the treatment of fungal diseases expressed by thrush on the tongue or candidal vaginosis. 314 
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When asked about the dosage, they further explained that it is usually taken with a small glass 315 
tumbler which can be measured to be about 100 mL, 3 to 4 times in a day.  It was observed that the 316 
leaves and fruits are the most frequently used plant parts for the treatments and this correlates with 317 
the findings of Rahmatullah et al., (2012), that the leaves of medicinal plants are used more often in 318 
traditional medicine than the other plant parts perhaps because leaves are easy to collect. The 319 
traditional healers cooperated with the investigating team and claimed that their methods were 320 
effective in the treatment of fungal infections. This study demonstrates that the traditional healers 321 
could easily identify P. guineense owing to their long practice of the use of extracts of this species 322 
in herbal medicine. Our results indicate that P. guineense is an important medicinal plant which is 323 
highly utilized in the treatment of fungal infections in Imo state, South- Eastern Nigeria and could 324 
be a source for the discovery of a new antifungal scaffolds for drug discovery. 325 
 326 
Table 3.  List of fungal diseases often treated with P. guineense herbal remedies in Imo state, South 327 
Eastern Nigeria and the symptoms used by the traditional healers to diagnose the fungal infections. 328 
Frequency means the number of healers that mentioned it. 329 
Diseases Local names  





Plant parts used Method of 
preparation  
Administration Frequency 










Taken orally 8 
Vaginal 
candidiasis 














Ọria  anya Eye itching, 
swollen of the 
eye 
Leaves Cold  and hot 
water infusion 
Administered 
in drops in the 
eye 
3 



















































Ọgbaukwu Reddish and 
swollen toes 




Soaked in mild 
alcohol local 
gin (Kai-kai) 
Taken orally 8 
























The leaf and fruit extracts of P. guineense were most frequently used for skin diseases, nail infections/ athlete’s foot, scalp ringworm 330 
and skin ringworm (recorded 8 times by the 20 traditional healers). Mouth infections/ Thrush and vaginal candidiasis were recorded 7 331 
and 6 times respectively. 332 
 333 
From previous reports, P. guineense extracts of the seed, fruit and leaf contained piperamide 334 
compounds such as piperine, dihydropiperine, piperylin, piperlonguminine, 335 
dihydropiperlonguminine, wisanine and dihydrowisanine (Adesina et al, 2003; Scott et al., 2005). 336 
However, to the best of our knowledge, no reports are available on the antifungal effects of isolated 337 
phytochemicals from P. guineense. The chemical structures of piperine, 4, 5-dihydropiperine, 338 
piperlonguminine, 4, 5-dihydropiperlonguminine, and piperylin are shown in Figure 2.  These 339 
bioactive compounds have been identified as the major bioactive compounds in P. guineense fruit 340 
extract (Scott et al., 2005). 341 
 342 
 Fig. 2. Chemical structures of some piperamide compounds in Piper guineense fruits  343 
 344 
3.2 Antifungal activity 345 
In the present study, a total of 12 extracts of various polarities from  the leaf and fruit of P. 346 
guineense, as well as hot water decoctions and cold water macerations were screened for antifungal 347 
activity against four yeast strains and C. neoformans (Table 4 and 5). Additionally, piperine and 348 
piperlongumine commercial piperamide compounds were also screened for antifungal activity. The 349 
screening was done based on our ethnobotanical results on the uses of P. guineense in West-African 350 
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traditional medicine for the treatment of fungal diseases (Table 3). For the investigation, some 351 
potentially pathogenic fungal strains of Candida spp. and Cryptococcus neoforamns, which could 352 
be responsible for some of the fungal diseases treated by the traditional healers were chosen. 353 
Among all the fungal strains selected, C. albicans is known to be the most significant human 354 
pathogenic species of yeast that can cause serious fungal diseases in humans (Brown et al., 2014). 355 
The extracts were found to exhibit marked antifungal activity against the various fungi used in our 356 
study and MIC values, as low as 39 μg/mL were recorded against some of the fungal strains (Table 357 
5). Our results are in agreement with a previous report that fractions, natural compounds and 358 
extracts from P. guineense can be explored as antifungal agents in the prevention of skin infection 359 
(Ngane et al., 2003). Moreover, evaluation of the antifungal potentials of P. guineense extracts 360 
along with other Cameroonian spices, revealed that the fruit extract of P. guineense is effective 361 
against C. albicans, C. parapsilosis, C. tropicalis, C. neoformans, and C. glabrata with MIC values 362 
ranging from 1560-6250 µg/mL (Dzoyem et al., 2014). Compared to this study, we recorded even 363 
lower MIC and MFC values which could be due to different kinds of extraction methods, Dzoyem 364 
et al. (2014) using only methanol: dichloromethane (3:1), but not sequential extraction.  365 
Generally, from our study, we observed that the leaf extracts showed a different spectrum of 366 
activity compared to the fruits.  For example, the hexane leaf extract showed an inhibition zone of 367 
21.7 mm against C. albicans, whereas the hexane fruit extract only gave an IZ of 14.3 mm against 368 
this fungus. The result correlated well with the MIC values, which were recorded to be 78 μg/mL 369 
for the leaf extract and 625 μg/mL for the fruit extract (Table 5). A similar trend was observed with 370 
the leaf extract in ethanol which gave an inhibition zone of 23.8 mm, whereas the fruit extract gave 371 
an IZ of 22.2 mm against Cryptococcus neoformans.  The MIC values were 78 μg/mL and 156 372 
μg/mL, respectively. However, this could be attributed to the fact that the concentration of the 373 
antifungal compounds varies between different extracts, thus, this result demonstrates that the 374 
leaves might contain a larger quantity of the bioactive compounds responsible for the antifungal 375 
activity compared to the fruit extracts. This result could be supported by our ethnobotanical survey 376 
results, where the traditional healers explained that the leaves of P. guineense are sometimes more 377 
active in the treatment of some of the fungal infections and are therefore used more frequently than 378 
the fruit for some specific symptoms of fungal infection. Moreover, our results are in accordance 379 
with Rahmatullah et al., (2012), who argued that the leaf extracts of medicinal plants are used more 380 
often in traditional medicine because they are usually more effective than extracts made from other 381 




Table 4. Antifungal effects of extracts of P. guineense, piperine and piperlongumine against four 384 
potentially pathogenic strains of yeast and Cryptococcus neoformans. Results obtained with the 385 
agar diffusion method.  386 
      


















  AI. Itra. 
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  AI. Itra. 
















PSH₂o٭ NA NA NA NA NA 
PSHH₂o NA NA NA NA NA 
PSEthanol 
  AI. Itra. 

















  AI. Itra. 

















   AI. Itra. 

















  AI. Itra. 
















PLH₂o٭ NA NA NA NA NA 
PLHH₂o NA NA NA NA NA 
PLEthanol 
  AI. Itra. 
















      
Pure compounds      
Piperine 
  AI. Itra. 

















  AI. Itra. 
















      
Antifungal drugs      
Itraconazole 



























      
Solvent controls      
Methanol  2.3 2,8 NA NA NA 
Chloroform NA NA NA NA NA 
Hexane 3,8 2,3 NA NA NA 
Ethanol NT 3, 7 NT 2, 3 NA 
The diameter of the zones of inhibition in mm as the mean of triplicates (n = 3) ± SEM (standard error of mean). 200µL of extracts 387 
and fractions (50 mg/mL), as well as pure compounds and antibiotics (10 mg/mL) were applied in the wells.  PSMeOH, P. guineense 388 
fruit methanol extract; PSCHCL3, P. guineense fruit chloroform extract; PSHex, P. guineense fruit hexane extract; PSH₂o٭, P. 389 
guineense fruit cold water maceration; PSHH₂o, P. guineense fruit hot water decoction; PSEthanol, P. guineense fruit ethanol 390 
extract; PLMeOH, P. guineense leaf methanol extract; PLCHCL3, P. guineense leaf chloroform extract; PLHex, P. guineense leaf 391 
hexane extract; PLH₂o٭, P. guineense leaf cold water maceration; PLHH₂o, P. guineense leaf hot water decoction; PLEthanol, P. 392 
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guineense leaf ethanol extract; AI Itra., activity index in relation to itraconazole; AI Amp., activity index in relation to amphotericin 393 
B; NA, not active and NT, not tested. The results marked with bold show promising antifungal activity. 394 
Interestingly, the water extracts were not active against the fungal strains evaluated in our study. 395 
Our results are consistent with a previous report that cold water macerations and hot water 396 
decoctions of P. guineense are not active against C. albicans and other Candida spp. (Okigbo and 397 
Igwe, 2007). Contrary to our results, water extracts of P. guineense are used in traditional medicine 398 
for fungal infections, even though it is sometimes administered as herbal formulations in 399 
combination with other medicinal plants, and often mixed with the local gin (Table 3). In our study, 400 
we observed that some of the alcohol and n-hexane extracts have marked antifungal activity with 401 
MIC values as low as 39 μg/mL, and  the inhibitory activity recorded with these extracts could 402 
result from their piperamide compounds, which are not well dissolved in water. It is possible that 403 
the water extracts contain only small quantities of piperamide alkaloids, which might explain their 404 
inactivity against the yeasts. The water extracts may contain other bioactive compounds than 405 
alkaloids, and thus P. guineense water extracts might be better to use in combination with other 406 
medicinal plants as herbal remedy for treatment of fungal infections in traditional medicine, which 407 
could explain the uses of P. guineense water extracts as concoctions for fungal infections in West-408 
African traditional medicine.  409 
Our results demonstrate that the ethanol fruit and leaf extracts of P. guineense give good growth 410 
inhibition against C. albicans (IZ 21.8 mm and 19.8 mm, respectively) (Table 4), and accordingly 411 
both extracts gave low MIC values of 78 µg/mL against C. albicans. C. albicans is an opportunistic 412 
pathogenic fungus that can cause serious systemic infections in humans, affecting mostly 413 
individuals with compromised immune defences, such as HIV/AIDS patients and elderly people 414 
(Brown et al., 2014). C. albicans is the main causative agent of candidiasis and our results are in 415 
agreement with the traditional uses of the fruits and leaves soaked in mild alcohol for the treatment 416 
of vaginal candidiasis (Table 3). Our result is also consistent with a previous report by Ejele et al., 417 
(2012), that ethanol extracts of P. guineense have significant activity against C. albicans.  We also 418 
observed significant and promising growth inhibitory results of 20.3 mm and 19.7 mm with the 419 
methanol fruit and leaf extracts against C. albicans.  Moreover, the chloroform extracts were active 420 
against C. albicans with a MIC value of 78 µg/mL for the leaf and fruit extracts. In our screenings, 421 
piperlongumine was found to be very active against C. albicans with a MIC value of 39 µg/mL, 422 
while piperine gave a MIC of 78 µg/mL. To the best of our knowledge, the inhibitory efficacy of 423 
piperlongumine has not been tested against C. albicans, and little information is available on the 424 
activity of piperine on Candida species. Since there is a report of multi-drug resistance in C. 425 
albicans (Gulshan and Moye-Rowley, (2007), our result demonstrates that piperlongumine and 426 
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piperine could be scaffolds for new natural plant derived antifungal agents to combat multi-drug 427 
resistance in Candida strains. More research should be conducted to ascertain the antifungal 428 
mechanism of action of piperamide alkaloids as well as on producing extracts of P. guineense 429 
leaves or fruits which would be standardized to their piperamide alkaloid contents.  430 
In comparison to our results with the plant extracts and alkaloids, our amphotericin-B standard drug 431 
showed a large inhibitory zone of 35.7 mm and a MIC of 0.48 µg/mL against C. albicans. The 432 
activity of P. guineense extracts and its piperamide alkaloids on C. albicans demonstrates that its 433 
extracts and alkaloids could be effectively utilized in combinations with conventional antifungals 434 
for the treatment of infections caused by antibiotic resistant C.  albicans strains. 435 
We also recorded promising growth inhibitory effects against C. glabrata, the second most 436 
significant human pathogenic species of yeast.The methanol, chloroform, and hexane extracts were 437 
all more active against C. glabrata than itraconazole (Table 4). Methanol and chloroform extracts 438 
gave the largest inhibition zones against C. glabrata (IZ ranging from 24.3 mm to 20.7 mm) (Table 439 
4). The MIC value for the chloroform fruit extract was 78 µg/mL. Notably, itraconazole was only 440 
moderately active against C. glabrata, with an inhibition zone of 16.3mm and a MIC value of 15.6 441 
µg/mL.  Drug-resistance against itraconazole has been found to be associated with 5% of 442 
nosocomial isolates of C. glabrata (Walker et al., 2013), and our results demonstrate that extracts of 443 
P. guineense could be sources for new antifungal scaffolds and drug adjuvants against drug resistant 444 
C. glabrata. A very low MIC value of 0.48 µg/mL was recorded with amphotericin B against C. 445 
glabrata, and our result is in agreement with the more frequent use of amphotericin B for the 446 
treatment of severe infections caused by C. glabrata (Mario et al., 2012). Piperine was active 447 
against C. glabrata with a MIC of 78 µg/mL, while piperlongumine was moderately active with a 448 
MIC value of 156 µg/mL. Apart from C. albicans, C. glabrata is another important fungal pathogen 449 
responsible for systemic infections which are associated with high mortality rate (Pfaller et al., 450 
2004; 2007). Our results demonstrate that the extracts and the piperamide compounds could be 451 
possible sources and antifungal drug scaffolds for the discovery of a new antifungal drugs and drug 452 
adjuvants for the treatment of systemic infections caused by C. glabrata.  453 
 454 
Table 5. Minimum inhibitory concentration and minimum fungicidal concentrations (MIC and 455 
MFC) in µg/mL of fruit and leaf extracts of Piper guineense and the alkaloids piperine and 456 
piperlongumine  457 
 458 
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MIC value represents mean of triplicates. MIC, minimum inhibitory concentration; MFC, minimum fungicidal concentration. For 459 
key to other abbreviations, see Table 4. Only extracts with promising antifungal effect in the agar disk diffusion assay were tested for 460 
MIC. The MFC was evaluated by taking 100 µL from the wells containing extracts of the MIC concentration and 2 times and 4 times 461 
the MIC concentrations and inoculating on a petri dish for 48 hours. The MFC was taken as the lowest concentration where no 462 
visible growth was observed after the incubation. The results marked with bold show promising MIC values. 463 
For Candida tropicalis, the methanol fruit extract gave the largest inhibition zone (IZ 21.3 mm) and 464 
a MIC value of 39 µg/mL. The MIC value for piperine against this fungus was 78 µg/mL and thus 465 
was less effective than the methanol fruit extract. Piperine has been reported to be one of the main 466 
piperamide compounds found in P. guineense (Scott et al., 2005). Our result could indicate that 467 
some other piperamide compounds in the methanol fruit extract could be responsible for the good 468 
growth inhibitory effects of the extract, or then that these compounds act in synergy together with 469 
piperine to produce a lower MIC than that of pure piperine. The other extracts of the fruits were 470 
moderately active against C. tropicalis with inhibition zones ranging from 19.8 to 11.0 mm (Table 471 
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4).  The methanol leaf extract was also active against the fungus with a MIC of 78 µg/mL.The MIC 472 
value of the ethanol fruit and leaf extracts was found to be 78 µg/mL for both. In contrast to the 473 
other extracts, the decoctions and macerations showed no growth inhibition against C. tropicalis. 474 
All extracts, except for the macerations and decoctions were active against C. parapsilopsis with 475 
MIC values ranging from 312 to 625 µg/mL. The largest inhibition zone of 28.7 mm and 18.0 mm 476 
were recorded for a methanol leaf and fruit extract, respectively. A mixture of methanol-477 
dichloromethane (3:1 v/v) of the fruit extract of P. guineense has been previously found to be active 478 
against this fungus with a MIC value of 625 µg/mL (Dzoyem et al., 2014). Our result indicates that 479 
pure methanol is a better extractant for antifungals than methanol-dichloromethane (3:1), since we 480 
recorded a larger inhibition zone of 28.7 mm and a lower MIC value of 312 µg/mL with the 481 
methanol leaf extract compared to Dzoyem et al., (2014). The growth inhibitory effect of the 482 
ethanol extracts were not tested against C. parapsilopsis due to lack of material. Piperine and 483 
piperlongumine were active against C. parapsilosis with inhibition zones of 23.3 and 16.3 mm, 484 
respectively. The MIC values for piperine and piperlongumine were found to be 39 µg/mL and 156 485 
µg/mL, respectively. Thus, piperine could be responsible for some of the good activity displayed by 486 
the methanol leaf extract. 487 
 488 
In our study, P. guineense extracts were active against Cryptococcus neoformans. The largest 489 
inhibitory activity was observed with the ethanol leaf and fruit extracts (23.8 mm and 22.2 mm) 490 
(Table 4). The MIC values for the ethanol leaf and fruit extracts were in agreement with the agar 491 
diffusion result (78 µg/mL and 156 µg/mL respectively). The methanol leaf and fruit extracts 492 
recorded inhibition zones of 21.3 mm and 19.7 mm respectively, and their MIC values were 493 
recorded to be 156 µg/mL for both. It was observed that the leaf extracts of P. guineense were more 494 
active against this fungus than the fruits extracts. The chloroform fruit and leaf extracts were active 495 
against the fungus with inhibition zones of 18.2 mm and 17.3 mm. The hexane fruit and leaf 496 
extracts were moderately active also (IZ 14.3 mm and 11.7 mm). The MIC values for the 497 
chloroform and hexane extracts against this fungus were 156 µg/mL and 2500 µg/mL, respectively. 498 
Our result is consistent with one previous report that P. guineense fruit extract has growth inhibitory 499 
activity against C. neoformans with a MIC of 312 µg/mL (Dzoyem et al., 2014).  Piperine and 500 
piperlongumine were active with a MIC of 312 µg/mL for both.  501 
 502 
Conclusion 503 
P. guineense extracts, piperine and piperlongumine have been found to possess interesting 504 
antifungal properties as recorded in this study. The antifungal efficacy of the methanol, ethanol, 505 
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chloroform and n-hexane extracts of the fruit and leaf of P. guineense, as well as piperine and 506 
piperlongumine on various C. albicans and non- albicans Candida strains supports the use of P. 507 
guineense in the treatment of fungal infections in traditional medicine and demonstrates that 508 
extracts from this plant could contain bioactive compounds that could be utilized as therapeutic 509 
agents or scaffolds for the production of new antifungal drugs to treat diseases associated with 510 
Candida species and Cryptococcus neoformans. The study demonstrated that the extracts and 511 
piperamide compounds exert promising antifungal properties against pathogenic Candida albicans 512 
and other non-albicans Candida strains. Moreover, various extracts, especially from P. guineense 513 
leaves, showed a promising growth inhibitory profile against Cryptococcus neoformans which is 514 
known to cause life-threatening meningitis in immunocompromised individuals. In view of this 515 
current knowledge on alkaloids of P. guineense as antifungal agents, we recommend that additional 516 
research should be done to evaluate the in vivo antifungal properties of the extracts and piperamide 517 
compounds from P. guineense with some animal models. The marked inhibitory activity recorded 518 
with piperine and piperlongumine against C. albicans revealed that they could be good antifungal 519 
agents. Further research is needed to evaluate the inhibitory activity of these piperamide compounds 520 
in combination with currently known standard antibiotics because piperine and piperlongumine 521 
could possibly enhance the effects of the currently available antifungal drugs for the treatment of 522 
fungal infections. This study has clarified and broadened the traditional knowledge on the uses of P. 523 
guineense as an antifungal remedy in African traditional medicine. Systematic studies are in 524 
progress and for further investigations, HPLC-DAD and UHPLC/Q-TOF MS analysis are currently 525 
being conducted by our research team to characterize and identify the compounds present in the 526 
extracts with promising antifungal activity.  527 
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Appendix A. Supplementary material 554 
 Questionnaire used for the ethnobotanical survey on the traditional use of Piper guineense for the 555 
treatment of fungal infections in Imo state, South Eastern Nigeria. 556 
 We are researchers from the University of Helsinki, Finland and Federal University of Technology 557 
Owerri, Imo state, Nigeria. We would like to know the various methods that you use for utilization 558 
of Uziza (Piper guineense) for the treatment of fungal infections. 559 
1. Gender     Male □        Female □ 560 
2. What is your name (optional)…………………………………………………………….. 561 
3. What is your major occupation? :  a). Herbalist □   b). Traditional medical practitioner  □ 562 
c). Traditional healer/ herb seller □    d). Other □ 563 
4.  What is your age? :    a). 20-35 □     36 – 55 □       56 – 75 □ 564 
5.  For how long have you been practicing traditional medicine? : a) 1 – 15 years □     565 
      16 -30 years □     31 years and above □ 566 
 6. What is your source of knowledge of traditional medicine? : a). Inherited/learnt from parents □ 567 
    Training from other herbalists □     Other □ 568 
7.  What is your level of education? : a). University education □    High school □    569 
      Primary education □      No formal education □   570 
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8. What is your religion? : a) Christianity □          Traditionalist □      Islam □     Other □ 571 












11.  What are the symptoms and how do you diagnose this fungal infections? 
          
 
Fungal infections Local name Method of diagnosis/ 
symptoms 
   
   
   
   
   
   
   
 
12. Which part of the plant do you often use?:    Fruit □     Leaves □    Roots □   Other □ 
 
13. How do you get the Piper guineense used for the treatment? : a) Cultivate them □     b) Buy    
from the market □     c) Collect from the wild forest and bushes □     d) Other □ 
 
14. What are the method of preparations and administrations? 
        
Fungal diseases Method of preparation Mode of administration 
   
   
   
   
   
   








16. What do you do if you observe that the patient is not responding to your antifungal treatment? 575 
……………………………………………………………………………………………. 576 
Do you have some general comment about the possible challenges you face in your daily treatment 577 
of fungal infections using Piper guineense extracts? 578 
…………………………………………………………………………………………….. 579 
 580 
Thank you for your cooperation. 581 
         582 
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